Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Walgreens Boots Alliance (NQ: WBA )

9.380 -0.070 (-0.74%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 28, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 24,787,081
Open 9.450
Bid (Size) 9.350 (6)
Ask (Size) 9.360 (72)
Prev. Close 9.450
Today's Range 9.140 - 9.480
52wk Range 9.140 - 27.05
Shares Outstanding N/A
Dividend Yield 20.47%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Walgreens Boots Alliance Plunged Today
Major drug companies are increasingly going direct-to-consumer. 
Via The Motley Fool
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Performance

YTD
-64.80%
-64.80%
1 Month
-21.44%
-21.44%
3 Month
-37.00%
-37.00%
6 Month
-55.67%
-55.67%
1 Year
-63.24%
-63.24%

More News

Read More
The Boulder Group Arranges Sale of Net Leased Chipotle Property in Chicago MSA
Via AB Newswire
WALGREENS BOOTS ALLIANCE, INC. (NASDAQ: WBA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Walgreens Boots Alliance, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Check Out What Whales Are Doing With WBA
Via Benzinga
Large-Cap Stocks In Trouble: The 10 Worst Performers - Sunday, Aug. 25
Via Talk Markets
3 Struggling Stocks That Aren't Worth Buying on the Dip
Via The Motley Fool
Evolent Health Explores Sale, Garners Inbound Interest From Private Equity Firms
Via Benzinga
Walgreens Is Reportedly Considering a Drastic Move to Improve Its Cash Flow
Via The Motley Fool
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Walgreens Boots Alliance, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WBA
From The Rosen Law Firm PA
Via GlobeNewswire
How To Build A Dividend Growth Portfolio In An Overpriced Market
Via Talk Markets
Topics Stocks
Exposures US Equities
America's Future: Walgreens Versus Costco
Via Benzinga
Wall Street's Most Accurate Analysts Spotlight On 3 Defensive Stocks Delivering High-Dividend Yields
Via Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics, Walgreens, Vicor, and American Airlines and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
WBA Investors Have Opportunity to Lead Walgreens Boots Alliance, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
With Shares Down Over 60%, Is Now the Time to Buy This Healthcare Stock?
Via The Motley Fool
3 Brand-Name Ultra-High-Yield Dividend Stocks Billionaires Can't Stop Buying
Via The Motley Fool
The Boulder Group Arranges Sale of Net Lease Caliber Collision Property in Michigan
Via AB Newswire
Auto Stocks, Abortion, Health Care In Spotlight At DNC: Joe Biden, UAW President, Women Affected By Roe V. Wade Decision Headline Night 1
Via Benzinga
WALGREENS BOOTS ALLIANCE, INC. (NASDAQ: WBA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Walgreens Boots Alliance, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Walgreens and BARDA Form Strategic Partnership to Strengthen Decentralized Clinical Trials Model and Reporting
From Walgreens
Via Business Wire
Pharmacy Chains Like CVS Health, Walgreens Boots Alliance Confront Shifting Consumer Habits And Profit Pressures
Via Benzinga
Want $1,000 in Dividend Income? Here's How Much You Have to Invest in Walgreens Stock
Via The Motley Fool
Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers
Via Talk Markets
Is Cash Flow a Problem for Walgreens Boots Alliance?
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.